SU1337098A1 - Method of treatment of duodenal peptic ulcer - Google Patents

Method of treatment of duodenal peptic ulcer Download PDF

Info

Publication number
SU1337098A1
SU1337098A1 SU833662633A SU3662633A SU1337098A1 SU 1337098 A1 SU1337098 A1 SU 1337098A1 SU 833662633 A SU833662633 A SU 833662633A SU 3662633 A SU3662633 A SU 3662633A SU 1337098 A1 SU1337098 A1 SU 1337098A1
Authority
SU
USSR - Soviet Union
Prior art keywords
treatment
day
aqueous solution
patient
peptic ulcer
Prior art date
Application number
SU833662633A
Other languages
Russian (ru)
Inventor
Александр Михайлович Уголев
Анатолий Александрович Крылов
Владимир Иванович Годецкий
Раулий Прокофьевич Натриошвили
Людмила Дмитриевна Чернова
Original Assignee
Институт Физиологии Им.И.П.Павлова
Ленинградский институт усовершенствования врачей им.С.М.Кирова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Институт Физиологии Им.И.П.Павлова, Ленинградский институт усовершенствования врачей им.С.М.Кирова filed Critical Институт Физиологии Им.И.П.Павлова
Priority to SU833662633A priority Critical patent/SU1337098A1/en
Application granted granted Critical
Publication of SU1337098A1 publication Critical patent/SU1337098A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Дл  сокращени  сроков лечени  нар ду с лечебным питанием, приемом антацидов, спазмалитиков, холиноли- тиков, седативных препаратов дополнительно назначают оксигенированный водный раствор с содержанием кислорода 0,8-1,2 мас.% с рН 7-8,5 по 6080 мл ежечасно в течение 14-17 дней. ITo shorten the treatment time, along with medical nutrition, antacids, spasmolytics, cholinolytics, and sedatives, an oxygenated aqueous solution with an oxygen content of 0.8-1.2 wt.% With a pH of 7-8.5 and 6080 ml every hour is additionally prescribed. within 14-17 days. I

Description

113113

Изобретение относитс  к медицине, в частности к гастроэнтерологии.This invention relates to medicine, in particular to gastroenterology.

Целью изобретени   вл етс  сокращение сроков лечени .The aim of the invention is to reduce the duration of treatment.

Поставленна  цель достигаетс  тем что нар ду с лечебным питанием, приемом антацидов, спазмолитиков, холи- нолитиков, седативных препаратов, больным дополнительно назначают окси генированный водный раствор с содержанием кислорода 0,8-1,2% к массе с рН 7-8,5 по 60-80 мл ежечасно в течение 14-17 дней.This goal is achieved by the fact that, along with medical nutrition, taking antacids, antispasmodics, cholinolytics, sedatives, patients are additionally prescribed hydroxy aqueous solution with an oxygen content of 0.8-1.2% by weight with a pH of 7-8.5 60-80 ml hourly for 14-17 days.

Пример I, Больной К.В., 38 лет, диагноз:  звенна  болезнь,  зва луковицы двенадцатиперстной кишки , рубцово- звенна  деформаци  лу- ковищ). При первичном эндоскопичес- .ком осмотре вы влена  зва в луковице двенадцатиперстной кишки диаметром 0,5 0,4 см. Больному назначен курс лечени  с применением диеты № 1, антацидов , спазмолитиков, холинолити Example I, Patient K.V., 38 years old, diagnosed with a link disease, anterior to the duodenal bulb, cicatricial link deformity of the onions). During the primary endoscopic examination, the heel of the duodenum with a diameter of 0.5 to 0.4 cm was detected. The patient was prescribed a course of treatment using the No. 1 diet, antacids, antispasmodics, cholinolitis

ков, седативных препаратов и оксиге- нированного водного раствора с содержанием кислорода 1,2% и рН 7,0 в дозе 660 мл/сут. по 60 мл ежечасно в течение дн . Болевой синдром купировалс  на 6 день. Медикаментозна  терапи  отменена. Продолжалось лечение диетой № 1 и оксигенированным водным раствором. При контрольном эндоскопическом исследовании на 15 день вы влено полное рубцевание  звы и значительное уменьшение поверхностных гастрических изменений. Больной вьтисан на 21 день в удовлетворительном состо нии., sedatives and an oxygenated aqueous solution with an oxygen content of 1.2% and a pH of 7.0 at a dose of 660 ml / day. 60 ml hourly for days. Pain syndrome was stopped on day 6. Drug therapy is canceled. Continued treatment with diet No. 1 and oxygenated aqueous solution. A final endoscopic examination on day 15 revealed complete cicatrization of ulcers and a significant reduction in superficial gastric changes. The patient was infected on day 21 in a satisfactory condition.

Пример 2. Больной З.Д., 44 года, диагноз:  звенна  болезнь,  зва луковицы двенадцатиперстной кишки. При первичном эндоскопическом осмотре вы влена  зва луковицы диаметром 0,6-0,4 см. Больному назначена обычна  комплексна  терапи  и ок- сигенированна  вода с содержанием кислорода 1,0% и рН 8,0 в дозе 700 мл/сут по 80 мл в течение дн . После купировани  болевого синдрома на п тый день медикаментозна  Терапи отменена. Продолжалось лечение диетой № 1 и оксигенированным водным раствором. При контрольном эндоскопическом исследовании на 16 день отмеВН1-1ИПИ Заказ 4070/7Example 2. Patient ZD, 44 years old, diagnosed with a link disease, of the duodenal ulcer. During the primary endoscopic examination, the bulbs of a diameter of 0.6-0.4 cm were detected. The patient was prescribed the usual complex therapy and oxygenated water with an oxygen content of 1.0% and a pH of 8.0 at a dose of 700 ml / day, 80 ml per day. for days After the relief of pain on the fifth day of the drug, therapies were canceled. Continued treatment with diet No. 1 and oxygenated aqueous solution. At the control endoscopic examination on the 16th day, mark VN1-1IPI Order 4070/7

Произв.-полигр. пр-тие, г. Ужгород, ул. Проектна , 4Random polygons pr-tie, Uzhgorod, st. Project, 4

00

чено рубцевание  звы и исчезновение поверхностных воспалительных изменений слизистой. Больной выписан на 20 день в удовлетворительном сое- то нин.scarring of the ulcers and the disappearance of superficial inflammatory mucosal changes. The patient was discharged on the 20th day in a satisfactory connection.

Пример 3. Больной С.К., 32 года, диагноз:  звенна  болезнь,  зва луковицы двенадцатиперстной кишки . При первичном эндоскопическом осмотре вы влена  зва луковицы 0,7 0,4 см. Больному назначен курс лечени  оксигенированным водным раствором с содержанием кислорода 0,8% иExample 3. Patient S.K., 32 years old, diagnosed with a link disease, of the duodenal ulcer. During the primary endoscopic examination, the bulb of 0.7 0.4 cm was detected. The patient was prescribed a course of treatment with an oxygenated aqueous solution with an oxygen content of 0.8% and

5 рН 8,5 в дозе 700 мл/сут {по 80 мл ежечасно в течение дн ), на фоне обычной комплексной терапии. На 6 день боли купировались и медикаментозна  терапи  отменена. Продолжа0 лось лечение оксигенированным водным раствором и диетой № 1. При контрольном эндоскопическом исследовании на 14 день вы влено уменьшение  звенного дефекта до 0,1 см и уменьшение5 pH 8.5 at a dose of 700 ml / day {80 ml every hour per day), against the background of the usual complex therapy. On day 6, the pains were relieved and drug therapy was canceled. The treatment with oxygenated aqueous solution and diet No. 1 was continued. A control endoscopic examination on day 14 revealed a decrease in the ulcer defect to 0.1 cm and a decrease in

25 поверхностных гастрических изменений слизистой. Больной выписан на 23 день в удовлетворительном состо нии.25 superficial gastric mucosal changes. The patient was discharged on the 23rd day in a satisfactory condition.

Применение оксигенированного водного раствора с рП 7,0 вызывало уThe use of an oxygenated aqueous solution with RP 7.0 caused

30 больны непри тные ощущени  в эпигас- тральной области и изжогу, а вода с рН 8,5 вызывала у больных непри тный привкус во рту и диспептические  в- , лени .30 patients had unpleasant sensations in the epigastric region and heartburn, and water with a pH of 8.5 caused an unpleasant taste in the mouth and dyspeptic v-, laziness in patients.

У Таким образом, применение оксигенированного водного раствора при  звенной болезни двенадцатиперстной приводит к уменьшению размеров  звы, ускорению ее рубцевани  и со40 кращению сроков лечени .Thus, the use of an oxygenated aqueous solution in duodenal ulcer leads to a reduction in the size of the ulcer, acceleration of its scarring and a reduction in the duration of treatment.

Claims (1)

Формула изобретени  Invention Formula Способ лечени   звенной болезни 45 двенадцатиперстной кишки путем назначени  лечебного питани , антацидов , спазмолитиков, холинолитиков. седативных препаратов с последующей пероральной терапией кислородом, о тлич.ающий с   тем, что, с целью сокращени  сроков лечени , дополнительно ввод т оксигенирован- ный водный раствор с рН 7,0 - 8,5 и содержанием кислорода 0,8 - 1,2% по массе в количестве 60 - 80 мл ежечасно в течение 14 - 17 дней.A method of treating duodenal ulcer 45 by administering therapeutic nutrition, antacids, antispasmodics, anticholinergics. sedatives followed by oral oxygen therapy, which is so that, in order to shorten the treatment time, an oxygenated aqueous solution with a pH of 7.0 - 8.5 and an oxygen content of 0.8 - 1.2 is added. % by weight in the amount of 60 - 80 ml hourly for 14 to 17 days. 5050 5555 Тираж 594Circulation 594 ПодписноеSubscription
SU833662633A 1983-11-15 1983-11-15 Method of treatment of duodenal peptic ulcer SU1337098A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SU833662633A SU1337098A1 (en) 1983-11-15 1983-11-15 Method of treatment of duodenal peptic ulcer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU833662633A SU1337098A1 (en) 1983-11-15 1983-11-15 Method of treatment of duodenal peptic ulcer

Publications (1)

Publication Number Publication Date
SU1337098A1 true SU1337098A1 (en) 1987-09-15

Family

ID=21089165

Family Applications (1)

Application Number Title Priority Date Filing Date
SU833662633A SU1337098A1 (en) 1983-11-15 1983-11-15 Method of treatment of duodenal peptic ulcer

Country Status (1)

Country Link
SU (1) SU1337098A1 (en)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011519861A (en) * 2008-05-01 2011-07-14 レバレジオ コーポレイション Compositions and methods for treating gastrointestinal disorders
US8349191B2 (en) 1997-10-24 2013-01-08 Revalesio Corporation Diffuser/emulsifier for aquaculture applications
US8410182B2 (en) 2006-10-25 2013-04-02 Revalesio Corporation Mixing device
US8445546B2 (en) 2006-10-25 2013-05-21 Revalesio Corporation Electrokinetically-altered fluids comprising charge-stabilized gas-containing nanostructures
US8784897B2 (en) 2006-10-25 2014-07-22 Revalesio Corporation Methods of therapeutic treatment of eyes
US8784898B2 (en) 2006-10-25 2014-07-22 Revalesio Corporation Methods of wound care and treatment
US8815292B2 (en) 2009-04-27 2014-08-26 Revalesio Corporation Compositions and methods for treating insulin resistance and diabetes mellitus
US9198929B2 (en) 2010-05-07 2015-12-01 Revalesio Corporation Compositions and methods for enhancing physiological performance and recovery time
US9402803B2 (en) 2006-10-25 2016-08-02 Revalesio Corporation Methods of wound care and treatment
US9492404B2 (en) 2010-08-12 2016-11-15 Revalesio Corporation Compositions and methods for treatment of taupathy
US9523090B2 (en) 2007-10-25 2016-12-20 Revalesio Corporation Compositions and methods for treating inflammation
US9745567B2 (en) 2008-04-28 2017-08-29 Revalesio Corporation Compositions and methods for treating multiple sclerosis
US10125359B2 (en) 2007-10-25 2018-11-13 Revalesio Corporation Compositions and methods for treating inflammation

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8349191B2 (en) 1997-10-24 2013-01-08 Revalesio Corporation Diffuser/emulsifier for aquaculture applications
US9034195B2 (en) 1997-10-24 2015-05-19 Revalesio Corporation Diffuser/emulsifier for aquaculture applications
US9004743B2 (en) 2006-10-25 2015-04-14 Revalesio Corporation Mixing device for creating an output mixture by mixing a first material and a second material
US8445546B2 (en) 2006-10-25 2013-05-21 Revalesio Corporation Electrokinetically-altered fluids comprising charge-stabilized gas-containing nanostructures
US9512398B2 (en) 2006-10-25 2016-12-06 Revalesio Corporation Ionic aqueous solutions comprising charge-stabilized oxygen-containing nanobubbles
US8449172B2 (en) 2006-10-25 2013-05-28 Revalesio Corporation Mixing device for creating an output mixture by mixing a first material and a second material
US8470893B2 (en) 2006-10-25 2013-06-25 Revalesio Corporation Electrokinetically-altered fluids comprising charge-stabilized gas-containing nanostructures
US8784897B2 (en) 2006-10-25 2014-07-22 Revalesio Corporation Methods of therapeutic treatment of eyes
US8784898B2 (en) 2006-10-25 2014-07-22 Revalesio Corporation Methods of wound care and treatment
US9511333B2 (en) 2006-10-25 2016-12-06 Revalesio Corporation Ionic aqueous solutions comprising charge-stabilized oxygen-containing nanobubbles
US9402803B2 (en) 2006-10-25 2016-08-02 Revalesio Corporation Methods of wound care and treatment
US8962700B2 (en) 2006-10-25 2015-02-24 Revalesio Corporation Electrokinetically-altered fluids comprising charge-stabilized gas-containing nanostructures
US8410182B2 (en) 2006-10-25 2013-04-02 Revalesio Corporation Mixing device
US10125359B2 (en) 2007-10-25 2018-11-13 Revalesio Corporation Compositions and methods for treating inflammation
US9523090B2 (en) 2007-10-25 2016-12-20 Revalesio Corporation Compositions and methods for treating inflammation
US9745567B2 (en) 2008-04-28 2017-08-29 Revalesio Corporation Compositions and methods for treating multiple sclerosis
US8980325B2 (en) 2008-05-01 2015-03-17 Revalesio Corporation Compositions and methods for treating digestive disorders
EP2285347A4 (en) * 2008-05-01 2011-09-21 Revalesio Corp Compositions and methods for treating digestive disorders
JP2011519861A (en) * 2008-05-01 2011-07-14 レバレジオ コーポレイション Compositions and methods for treating gastrointestinal disorders
US9272000B2 (en) 2009-04-27 2016-03-01 Revalesio Corporation Compositions and methods for treating insulin resistance and diabetes mellitus
US8815292B2 (en) 2009-04-27 2014-08-26 Revalesio Corporation Compositions and methods for treating insulin resistance and diabetes mellitus
US9011922B2 (en) 2009-04-27 2015-04-21 Revalesio Corporation Compositions and methods for treating insulin resistance and diabetes mellitus
US9198929B2 (en) 2010-05-07 2015-12-01 Revalesio Corporation Compositions and methods for enhancing physiological performance and recovery time
US9492404B2 (en) 2010-08-12 2016-11-15 Revalesio Corporation Compositions and methods for treatment of taupathy

Similar Documents

Publication Publication Date Title
SU1337098A1 (en) Method of treatment of duodenal peptic ulcer
Jordan Surgical management of postgastrectomy problems
EP0055118A1 (en) Arthritis treatment
Lewis Iron and Copper in the Treatment of Anemia in Children
Goel et al. Dermatomyositis in childhood. Review of eight cases.
SU1105202A1 (en) Method of treatment of gastric ulcer and duodenal ulcer
Robinson Aspirin and the adrenal cortex
Kaplan The allantoin treatment of ulcers
SU1162084A1 (en) Method of treating patients after radiation lesion in acute period
Segal et al. A polyamine formaldehyde resin IV. Clinical evaluation in the treatment of duodenal ulcer
Moses einhorn The use of a new antispasmodic drug in gastro-enterology a preliminary report
RU2159631C1 (en) Method for stopping hemorrhages from gastroduodenal peptic ulcers
RU2191579C2 (en) Method of treatment of chronic gastritis and gastroduodenal ulcer associated with helicobacter pylori
De et al. Penicillin in Treatment of Diphtheria
SU1725902A1 (en) Method of children treatment with chronic tonsillitis
SU733684A1 (en) Preparation "alanton" for treating erosive gastritis
RU2178299C2 (en) Method to treat gastroduodenal ulcers
RU1780511C (en) Method for treating peptic ulcer, chronic gastritis and colitis
YOUMANS et al. GASTRIC TETANY: REPORT OF A CASE TREATED WITH AMMONIUM CHLORID
RU2004243C1 (en) Method for treating psoriasis
RU2240119C1 (en) Method for treatment of stomach and duodenum ulcerous disease
Ellis Vagotomy in the surgical treatment of pyloric stenosis
RU2192867C2 (en) Method for treating the cases of peptic gastric and duodenal ulcer disease
SU1641362A1 (en) Method for treatment patients suffering from renal colic
SU858829A1 (en) Method of treating virus hepatitis